Cargando…

Risk of adverse outcome of COVID-19 among patients in secure psychiatric services: observational cohort study

BACKGROUND: Secure forensic mental health services treat patients with high rates of treatment-resistant psychoses. High rates of obesity and medical comorbidities are common. Population-based studies have identified high-risk groups in the event of SARS-CoV-2 infection, including those with problem...

Descripción completa

Detalles Bibliográficos
Autores principales: Basrak, Natasa, Mulcrone, Naoise, Sharifuddin, Sue, Ghumman, Zeshan, Bechan, Nirvana, Mohamed, Enas, Murray, Michael, Rajendran, Hariharan, Gunnigle, Sean, Nolan, Mark, Quane, Tim, Terao, Masashi, Hoare, Tracey, Kirrane, Kevin, Kennedy, Harry G., Davoren, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804071/
https://www.ncbi.nlm.nih.gov/pubmed/33427191
http://dx.doi.org/10.1192/bjo.2020.169
_version_ 1783636082393350144
author Basrak, Natasa
Mulcrone, Naoise
Sharifuddin, Sue
Ghumman, Zeshan
Bechan, Nirvana
Mohamed, Enas
Murray, Michael
Rajendran, Hariharan
Gunnigle, Sean
Nolan, Mark
Quane, Tim
Terao, Masashi
Hoare, Tracey
Kirrane, Kevin
Kennedy, Harry G.
Davoren, Mary
author_facet Basrak, Natasa
Mulcrone, Naoise
Sharifuddin, Sue
Ghumman, Zeshan
Bechan, Nirvana
Mohamed, Enas
Murray, Michael
Rajendran, Hariharan
Gunnigle, Sean
Nolan, Mark
Quane, Tim
Terao, Masashi
Hoare, Tracey
Kirrane, Kevin
Kennedy, Harry G.
Davoren, Mary
author_sort Basrak, Natasa
collection PubMed
description BACKGROUND: Secure forensic mental health services treat patients with high rates of treatment-resistant psychoses. High rates of obesity and medical comorbidities are common. Population-based studies have identified high-risk groups in the event of SARS-CoV-2 infection, including those with problems such as obesity, lung disease and immune-compromising conditions. Structured assessment tools exist to ascertain the risk of adverse outcome in the event of SARS-CoV-2 infection. AIMS: To assess risk of adverse outcome in the event of SARS-CoV-2 infection in a complete population of forensic psychiatry patients using structured assessment tools. METHOD: All patients of a national forensic mental health service (n = 141) were rated for risk of adverse outcome in the event of SARS-CoV-2 infection, using two structured tools, the COVID-Age tool and the COVID-Risk tool. RESULTS: We found high rates of relevant physical comorbidities. Mean chronological age was 45.5 years (s.d. = 11.4, median 44.1), mean score on the COVID-Age tool was 59.1 years (s.d. = 19.4, median 58.0), mean difference was 13.6 years (s.d. = 15.6), paired t = 10.9, d.f. = 140, P < 0.001. Three patients (2.1%) were chronologically over 70 years of age, compared with 43 (30.5%) with a COVID-Age over 70 (χ(2) = 6.99, d.f. = 1, P = 0.008, Fisher's exact test P = 0.027). CONCLUSIONS: Patients in secure forensic psychiatric services represent a high-risk group for adverse outcomes in the event of SARS-COV-2 infection. Population-based guidance on self-isolation and other precautions based on chronological age may not be sufficient. There is an urgent need for better physical health research and treatment in this group.
format Online
Article
Text
id pubmed-7804071
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-78040712021-01-13 Risk of adverse outcome of COVID-19 among patients in secure psychiatric services: observational cohort study Basrak, Natasa Mulcrone, Naoise Sharifuddin, Sue Ghumman, Zeshan Bechan, Nirvana Mohamed, Enas Murray, Michael Rajendran, Hariharan Gunnigle, Sean Nolan, Mark Quane, Tim Terao, Masashi Hoare, Tracey Kirrane, Kevin Kennedy, Harry G. Davoren, Mary BJPsych Open Papers BACKGROUND: Secure forensic mental health services treat patients with high rates of treatment-resistant psychoses. High rates of obesity and medical comorbidities are common. Population-based studies have identified high-risk groups in the event of SARS-CoV-2 infection, including those with problems such as obesity, lung disease and immune-compromising conditions. Structured assessment tools exist to ascertain the risk of adverse outcome in the event of SARS-CoV-2 infection. AIMS: To assess risk of adverse outcome in the event of SARS-CoV-2 infection in a complete population of forensic psychiatry patients using structured assessment tools. METHOD: All patients of a national forensic mental health service (n = 141) were rated for risk of adverse outcome in the event of SARS-CoV-2 infection, using two structured tools, the COVID-Age tool and the COVID-Risk tool. RESULTS: We found high rates of relevant physical comorbidities. Mean chronological age was 45.5 years (s.d. = 11.4, median 44.1), mean score on the COVID-Age tool was 59.1 years (s.d. = 19.4, median 58.0), mean difference was 13.6 years (s.d. = 15.6), paired t = 10.9, d.f. = 140, P < 0.001. Three patients (2.1%) were chronologically over 70 years of age, compared with 43 (30.5%) with a COVID-Age over 70 (χ(2) = 6.99, d.f. = 1, P = 0.008, Fisher's exact test P = 0.027). CONCLUSIONS: Patients in secure forensic psychiatric services represent a high-risk group for adverse outcomes in the event of SARS-COV-2 infection. Population-based guidance on self-isolation and other precautions based on chronological age may not be sufficient. There is an urgent need for better physical health research and treatment in this group. Cambridge University Press 2021-01-11 /pmc/articles/PMC7804071/ /pubmed/33427191 http://dx.doi.org/10.1192/bjo.2020.169 Text en © The Author(s) 2021 http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Papers
Basrak, Natasa
Mulcrone, Naoise
Sharifuddin, Sue
Ghumman, Zeshan
Bechan, Nirvana
Mohamed, Enas
Murray, Michael
Rajendran, Hariharan
Gunnigle, Sean
Nolan, Mark
Quane, Tim
Terao, Masashi
Hoare, Tracey
Kirrane, Kevin
Kennedy, Harry G.
Davoren, Mary
Risk of adverse outcome of COVID-19 among patients in secure psychiatric services: observational cohort study
title Risk of adverse outcome of COVID-19 among patients in secure psychiatric services: observational cohort study
title_full Risk of adverse outcome of COVID-19 among patients in secure psychiatric services: observational cohort study
title_fullStr Risk of adverse outcome of COVID-19 among patients in secure psychiatric services: observational cohort study
title_full_unstemmed Risk of adverse outcome of COVID-19 among patients in secure psychiatric services: observational cohort study
title_short Risk of adverse outcome of COVID-19 among patients in secure psychiatric services: observational cohort study
title_sort risk of adverse outcome of covid-19 among patients in secure psychiatric services: observational cohort study
topic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804071/
https://www.ncbi.nlm.nih.gov/pubmed/33427191
http://dx.doi.org/10.1192/bjo.2020.169
work_keys_str_mv AT basraknatasa riskofadverseoutcomeofcovid19amongpatientsinsecurepsychiatricservicesobservationalcohortstudy
AT mulcronenaoise riskofadverseoutcomeofcovid19amongpatientsinsecurepsychiatricservicesobservationalcohortstudy
AT sharifuddinsue riskofadverseoutcomeofcovid19amongpatientsinsecurepsychiatricservicesobservationalcohortstudy
AT ghummanzeshan riskofadverseoutcomeofcovid19amongpatientsinsecurepsychiatricservicesobservationalcohortstudy
AT bechannirvana riskofadverseoutcomeofcovid19amongpatientsinsecurepsychiatricservicesobservationalcohortstudy
AT mohamedenas riskofadverseoutcomeofcovid19amongpatientsinsecurepsychiatricservicesobservationalcohortstudy
AT murraymichael riskofadverseoutcomeofcovid19amongpatientsinsecurepsychiatricservicesobservationalcohortstudy
AT rajendranhariharan riskofadverseoutcomeofcovid19amongpatientsinsecurepsychiatricservicesobservationalcohortstudy
AT gunniglesean riskofadverseoutcomeofcovid19amongpatientsinsecurepsychiatricservicesobservationalcohortstudy
AT nolanmark riskofadverseoutcomeofcovid19amongpatientsinsecurepsychiatricservicesobservationalcohortstudy
AT quanetim riskofadverseoutcomeofcovid19amongpatientsinsecurepsychiatricservicesobservationalcohortstudy
AT teraomasashi riskofadverseoutcomeofcovid19amongpatientsinsecurepsychiatricservicesobservationalcohortstudy
AT hoaretracey riskofadverseoutcomeofcovid19amongpatientsinsecurepsychiatricservicesobservationalcohortstudy
AT kirranekevin riskofadverseoutcomeofcovid19amongpatientsinsecurepsychiatricservicesobservationalcohortstudy
AT kennedyharryg riskofadverseoutcomeofcovid19amongpatientsinsecurepsychiatricservicesobservationalcohortstudy
AT davorenmary riskofadverseoutcomeofcovid19amongpatientsinsecurepsychiatricservicesobservationalcohortstudy